This new amendment will effectively make ALL Hydrocodone containing products a
Schedule II drug. Hydrocodone alone has always been a
Schedule II drug; however, there are currently no drugs on the market that contain ONLY Hydrocodone. All Hydrocodone products on the US market are combined with either Tylenol (Acetaminophen), Ibuprofen, or Aspirin. There is a new Hydrocodone extended release med undergoing clinical trials called Zohydro that is expected to hit the market 2013-2014.